Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Cyclophosphamide and Nandrolone Decanoate in the Treatment of Advanced Carcinoma of the Breast—Results of a Comparative Controlled Trial of the Agents Used Singly and in Combination

British Journal of Cancer volume 27, pages 396–399 (1973)Cite this article

Abstract

A random trial in which cyclophosphamide, nandrolone decanoate and the two drugs in combination were used in the treatment of advanced breast carcinoma is described. The results suggest that it is preferable to use cyclophosphamide on its own.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Authors
  1. M P Cole
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I D H Todd
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P M Wilkinson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cole, M., Todd, I. & Wilkinson, P. Cyclophosphamide and Nandrolone Decanoate in the Treatment of Advanced Carcinoma of the Breast—Results of a Comparative Controlled Trial of the Agents Used Singly and in Combination. Br J Cancer 27, 396–399 (1973). https://doi.org/10.1038/bjc.1973.47

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1973.47

Search

Advanced search

Quick links